Evidence map›Paper›PMID 34593237›Full record

ArticleL'Encephale2021

The neuroinflammatory pathways of post-SARS-CoV-2 psychiatric disorders.

G Fond, M Masson, C Lançon, R Richieri, E Guedj

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in L'Encephale, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. BrainEuropean journal of nuclear medicine and molecular imaging · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

G FondEA 3279-EA 3279: CEReSS, Health Service Research and Quality of Life Center, Aix Marseille Université, 27, boulevard Jean Moulin, 13005 Marseille, France; Department of Medical Information and Public Health, AP-HM, Aix Marseille Université, 27, boulevard Jean Moulin, 13005 Marseille, France.
M MassonNightingale Hospitals-Paris, Clinique du Château de Garches, 11, bis rue de la Porte Jaune, 92380 Garches, France; Service Hospitalo-Universitaire, CH de Sainte-Anne, 1, rue Cabanis, 75014 Paris, France.
C LançonEA 3279-EA 3279: CEReSS, Health Service Research and Quality of Life Center, Aix Marseille Université, 27, boulevard Jean Moulin, 13005 Marseille, France; Department of Psychiatry, La Conception University Hospital, AP-HM, 147, boulevard Baille, 13005 Marseille, France.
R RichieriService Hospitalo-Universitaire, CH de Sainte-Anne, 1, rue Cabanis, 75014 Paris, France; Department of Psychiatry, La Conception University Hospital, AP-HM, 147, boulevard Baille, 13005 Marseille, France; Aix Marseille Université, CNRS, École Centrale Marseille, UMR 7249, Institut Fresnel, CERIMED, 27, boulevard Jean Moulin, 13005 Marseille, France.
E GuedjAix Marseille Université, CNRS, École Centrale Marseille, UMR 7249, Institut Fresnel, CERIMED, 27, boulevard Jean Moulin, 13005 Marseille, France; Nuclear Medicine Department, La Timone University Hospital, AP-HM, 264, rue Saint Pierre, 13005 Marseille, France. Electronic address: eric.guedj@ap-hm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Mental DisordersHumansSARS-CoV-2

Identifiers

PMID34593237
PMCPMC8403666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.